See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2021_AILERON_THERAPEUTICS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001420565')"} |
Graph
Absolute values for 0001420565, AILERON THERAPEUTICS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 16,326,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 15,000 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 3,960,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 219,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 9,330,000 |
9 | ResearchAndDevelopmentExpense | 11,166,000 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -661,000 |
13 | remainder_ComprehensiveNetIncome | -9,000 |
yvar | yval | |
---|---|---|
0 | Assets | 16,341,000 |
1 | Liabilities | 4,179,000 |
2 | Expenses | 20,496,000 |
3 | Revenues | 0 |
4 | StockholdersEquity | 12,162,000 |
5 | NetIncome | -21,157,000 |
6 | ComprehensiveNetIncome | -21,161,500 |
7 | BaseVar | 20,843,000 |
8 | EconomicCapitalRatio | -0.0237 |